| Literature DB >> 26868616 |
Chaochao Wu1, Jicheng Duan1, Tao Liu1, Richard D Smith1, Wei-Jun Qian2.
Abstract
Human biofluids, especially blood plasma or serum, hold great potential as the sources of candidate biomarkers for various diseases; however, the enormous dynamic range of protein concentrations in biofluids represents a significant analytical challenge for detecting promising low-abundance proteins. Over the last decade, various immunoaffinity chromatographic methods have been developed and routinely applied for separating low-abundance proteins from the high- and moderate-abundance proteins, thus enabling much more effective detection of low-abundance proteins. Herein, we review the advances of immunoaffinity separation methods and their contributions to the proteomic applications in human biofluids. The limitations and future perspectives of immunoaffinity separation methods are also discussed.Entities:
Keywords: Affinity proteomics; Biofluid; Biomarker discovery; Immunoaffinity chromatography; Immunodepletion; Immunoenrichment; Plasma/Serum; Proteomics
Mesh:
Substances:
Year: 2016 PMID: 26868616 PMCID: PMC4862894 DOI: 10.1016/j.jchromb.2016.01.015
Source DB: PubMed Journal: J Chromatogr B Analyt Technol Biomed Life Sci ISSN: 1570-0232 Impact factor: 3.205